Webinars and Sponsored Roundtables — Register Now
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The roundtable is made possible by a special educational grant from Pillar Biosciences.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.
Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Illumina.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Interactive Product Guides
Pathology Visions 2026: Connecting Innovation with Purpose
Event Details
Digital pathology is transforming how we diagnose, collaborate, innovate—and ultimately improve patient care. The conversations shaping the future are happening
Event Details
Digital pathology is transforming how we diagnose, collaborate, innovate—and ultimately improve patient care. The conversations shaping the future are happening at Pathology Visions 2026, October 16–18 in San Diego.
Join the Digital Pathology Association (DPA) for three days of expert education, meaningful collaboration, and the latest advancements in digital pathology and AI. Connect with more than 1,000 pathologists, researchers, laboratory leaders, healthcare professionals, and industry innovators who are driving the next era of precision medicine.
Under this year’s theme, “Connecting Innovation with Purpose,” Pathology Visions 2026 explores the journey of digital pathology from technical innovation to direct patient impact. Sessions will address real-world clinical applications, AI and patient outcomes, emerging technologies and trends, best practices for integrating digital pathology into clinical workflows, and more.
Attendees will have the opportunity to:
- Gain actionable insights from 100+ visionary speakers
- Explore cutting-edge solutions from 65+ exhibitors
- Discover the latest research through 50+ scientific poster presentations
- Participate in workshops, educational sessions, and networking opportunities
- Connect with leaders and innovators shaping the future of pathology
- Exchange ideas and explore strategies for advancing digital pathology and AI in patient care
Whether you’re looking to gain practical insights, discover emerging technologies, or expand your professional network, #PathVisions26 brings the pathology community together to exchange ideas, spark innovation, forge lasting partnerships, and shape the future of patient care.
Pathology Visions 2026 is an essential event for pathologists, laboratory and healthcare leaders, researchers, and others committed to advancing patient care through the power of digital pathology.
For more information and to register, visit: https://digitalpathologyassociation.org/pathology-visions-conference.
Time
Location
Manchester Grand Hyatt San Diego